| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8395c0e59dc8ab93a7e1a55884328664 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42918ab59290c9e98fa34d8d8fe1c056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9681029cfb585d5e0d15b01a9e9eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_127812caefe1b0c849314b8ddc776273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b5de13fccdd1d6ab4f0c7456dc45133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dedeb8c624ced2792ad7e00ddcf4c19d |
| publicationDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011166197-A1 |
| titleOfInvention |
Antisense Modulation Of Amyloid Beta Protein Expression |
| abstract |
Antisense nucleic acids, compositions and methods are provided for modulating the expression of an amyloid beta protein (AβP) portion of the amyloid precursor protein (APP) coding sequence. The compositions comprise antisense nucleic acids targeted to nucleic acids encoding amyloid precursor protein. Methods of using these nucleic acids for modulation of amyloid precursor protein expression and for treatment of diseases and conditions associated with expression of the amyloid beta protein portion of the amyloid precursor protein are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019169243-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10364432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466118-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732260-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018204408-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017226521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010196393-A1 |
| priorityDate |
2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |